Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06379581
Status:
RECRUITING
Last Update Posted:
2024-04-24
First Post:
2024-04-17
Brief Title:
Skin Cancer Diagnostics Using Photoacoustic Imaging
Sponsor:
Region Skane
Organization:
Region Skane
Study Overview
Official Title:
Photoacoustic Imaging for Three-dimensional Delineation of Skin Tumors
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this clinical study photoacoustic imaging will be used on patients with suspected skin cancer primarily melanoma basal cell carcinoma and squamous cell carcinoma to determine the tumor borders both superficially and at a depth
Detailed Description:
The study will employ multispectral photoacoustic imaging in the spectral range between 680-970 nm to scan suspected skin tumors both in vivo and ex vivo The hyperspectral data will then undergo rigorous spectral analysis with the objective to identify the spectral fingerprints associated with healthy tissue and tumor Thereafter a classification algorithm will be used to determine whether a pixel in the acquired image more likely identifies with healthy tissue or tumor which is then repeated for all pixels in the images As such a 3D image can be reconstructed in which the tumor is visibly contrasted from healthy tissue Achieving this goal will facilitate the diagnostic procedures and greatly reduce waiting times clinical costs and potential patient suffering
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None